PE20010209A1 - Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticas - Google Patents
Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticasInfo
- Publication number
- PE20010209A1 PE20010209A1 PE2000000520A PE0005202000A PE20010209A1 PE 20010209 A1 PE20010209 A1 PE 20010209A1 PE 2000000520 A PE2000000520 A PE 2000000520A PE 0005202000 A PE0005202000 A PE 0005202000A PE 20010209 A1 PE20010209 A1 PE 20010209A1
- Authority
- PE
- Peru
- Prior art keywords
- hours
- octan
- citrate
- amine
- refers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA FORMA CRISTALINA DEL CITRATO DE (2S,3S)-N-(METOXI-5-t-BUTILFENILMETIL-2-DIFENILMETIL-1-AZOBICICLO[2,2,2]OCTAN-3-AMINA DE FORMULA I; QUE SE CARACTERIZA PORQUE EL POLIMORFO A ESTABLE TIENE UN PATRON DE DIFRACCION DE RAYOS X, POR PRESENTARSE EN FORMA DE PLACAS; NO SER HIGROSCOPICO; SE VOLATIZA A APROXIMADAMENTE 116°C; LA TEMPERATURA DE COMIENZO DE LA FUSION ES DE 152,7°C; TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION QUE COMPRENDE ADICIONAR ACIDO CITRICO A UNA DISOLUCION DE LA BASE LIBRE EN ACETONA, DURANTE 2 HORAS, FILTRAR Y AGITAR LA SOLUCION TRASPARENTE DURANTE LA NOCHE, ADICIONAR EL ISOPROPIL ETER FILTRADO SEGUIDO DE LA ADICION DE AGUA FILTRADA, AGITAR LA MEZCLA RESULTANTE A TEMPERATURA AMBIENTE HASTA EL COMIENZO DE LA CRISTALIZACION, GRANULAR DURANTE 16 HORAS Y RECOGER LA SAL BLANCA CRISTALINA FORMADA POR FILTRACION Y SECAR A 45°C EN VACIO CON N DURANTE 24 HORAS. EL COMPUESTO I ES UN ANTAGONISTA DE LA SUSTANCIA P Y PUEDE SER UTIL PARA EL TRATAMIENTO DE LA EMESIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13699299P | 1999-06-01 | 1999-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010209A1 true PE20010209A1 (es) | 2001-03-01 |
Family
ID=22475338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000000520A PE20010209A1 (es) | 1999-06-01 | 2000-05-30 | Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticas |
Country Status (49)
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1713506A1 (en) * | 2004-01-30 | 2006-10-25 | Pfizer Products Incorporated | Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration |
RU2337685C2 (ru) * | 2004-01-30 | 2008-11-10 | Пфайзер Продактс Инк. | Антагонисты нейрокининового рецептора nk-1 для выхода из наркоза |
KR100834232B1 (ko) * | 2004-01-30 | 2008-05-30 | 화이자 프로덕츠 인크. | 액체 투여형용 베타-시클로덱스트린을 사용하는 다수회투여 제형을 얻기 위한 항균 방부제 |
RU2320659C9 (ru) * | 2004-02-02 | 2008-07-20 | Пфайзер Продактс Инк. | Способы получения 1-(2s, 3s)-2-бензгидрил-n-(5-трет-бутил-2-метоксибензил)хинуклидин-3-амина в виде камфорсульфатной соли, цитратной соли и свободного основания и промежуточное соединение |
KR102391332B1 (ko) * | 2013-03-15 | 2022-04-26 | 펄 테라퓨틱스 인코포레이티드 | 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템 |
CN110577522B (zh) * | 2018-06-07 | 2022-12-27 | 东莞市东阳光动物保健药品有限公司 | 马罗匹坦柠檬酸盐新晶型及其制备方法 |
CN112979639A (zh) * | 2019-12-16 | 2021-06-18 | 四川科瑞德凯华制药有限公司 | 一种马罗皮坦新晶型及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL171379B1 (en) * | 1991-05-31 | 1997-04-30 | Pfizer | Method of obtaining novel derivatives of quinuclidine |
US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
US5576317A (en) * | 1994-12-09 | 1996-11-19 | Pfizer Inc. | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
-
2000
- 2000-05-08 US US09/566,307 patent/US6255320B1/en not_active Expired - Lifetime
- 2000-05-17 HN HN2000000077A patent/HN2000000077A/es unknown
- 2000-05-18 TR TR2001/03473T patent/TR200103473T2/xx unknown
- 2000-05-18 IL IL14640600A patent/IL146406A0/xx not_active IP Right Cessation
- 2000-05-18 SK SK1733-2001A patent/SK285820B6/sk not_active IP Right Cessation
- 2000-05-18 CZ CZ20014269A patent/CZ295819B6/cs not_active IP Right Cessation
- 2000-05-18 JP JP2001500629A patent/JP3830816B2/ja not_active Expired - Lifetime
- 2000-05-18 NZ NZ515349A patent/NZ515349A/xx unknown
- 2000-05-18 OA OA1200100318A patent/OA11956A/en unknown
- 2000-05-18 EE EEP200100656A patent/EE200100656A/xx unknown
- 2000-05-18 MX MXPA01012325A patent/MXPA01012325A/es unknown
- 2000-05-18 DE DE60003679T patent/DE60003679T2/de not_active Expired - Lifetime
- 2000-05-18 WO PCT/IB2000/000665 patent/WO2000073304A1/en active IP Right Grant
- 2000-05-18 AP APAP/P/2001/002349A patent/AP2001002349A0/en unknown
- 2000-05-18 YU YU81101A patent/YU81101A/sh unknown
- 2000-05-18 CN CNB008082782A patent/CN1146565C/zh not_active Expired - Lifetime
- 2000-05-18 KR KR10-2001-7015494A patent/KR100476606B1/ko not_active IP Right Cessation
- 2000-05-18 HU HU0201301A patent/HUP0201301A3/hu unknown
- 2000-05-18 UA UA2001118214A patent/UA66925C2/uk unknown
- 2000-05-18 ES ES00925528T patent/ES2199825T3/es not_active Expired - Lifetime
- 2000-05-18 DK DK00925528T patent/DK1181290T3/da active
- 2000-05-18 AU AU44248/00A patent/AU767334B2/en not_active Expired
- 2000-05-18 EP EP00925528A patent/EP1181290B1/en not_active Expired - Lifetime
- 2000-05-18 EA EA200101108A patent/EA003731B1/ru active Protection Beyond IP Right Term
- 2000-05-18 CA CA002372238A patent/CA2372238C/en not_active Expired - Lifetime
- 2000-05-18 BR BR0011094-9A patent/BR0011094A/pt not_active Application Discontinuation
- 2000-05-18 PL PL00352716A patent/PL196046B1/pl not_active IP Right Cessation
- 2000-05-18 PT PT00925528T patent/PT1181290E/pt unknown
- 2000-05-18 AT AT00925528T patent/ATE244239T1/de not_active IP Right Cessation
- 2000-05-18 SI SI200030161T patent/SI1181290T1/xx unknown
- 2000-05-23 PA PA20008496101A patent/PA8496101A1/es unknown
- 2000-05-26 CO CO00039195A patent/CO5170463A1/es not_active Application Discontinuation
- 2000-05-26 TW TW089110206A patent/TWI285204B/zh not_active IP Right Cessation
- 2000-05-29 UY UY26176A patent/UY26176A1/es not_active Application Discontinuation
- 2000-05-30 AR ARP000102663A patent/AR033331A1/es active IP Right Grant
- 2000-05-30 MY MYPI20002409A patent/MY133508A/en unknown
- 2000-05-30 PE PE2000000520A patent/PE20010209A1/es not_active Application Discontinuation
- 2000-05-31 GT GT200000087A patent/GT200000087A/es unknown
- 2000-05-31 SV SV2000000093A patent/SV2001000093A/es unknown
- 2000-05-31 MA MA25997A patent/MA26742A1/fr unknown
- 2000-05-31 TN TNTNSN00120A patent/TNSN00120A1/fr unknown
- 2000-05-31 DZ DZ000101A patent/DZ3050A1/xx active
- 2000-06-01 EC EC2000003508A patent/ECSP003508A/es unknown
-
2001
- 2001-11-28 ZA ZA200109775A patent/ZA200109775B/en unknown
- 2001-11-30 NO NO20015848A patent/NO20015848L/no not_active Application Discontinuation
- 2001-12-04 HR HR20010904A patent/HRP20010904A2/hr not_active Application Discontinuation
- 2001-12-10 BG BG106204A patent/BG65240B1/bg unknown
-
2002
- 2002-10-30 HK HK02107879A patent/HK1046284A1/xx not_active IP Right Cessation
-
2007
- 2007-03-27 CY CY2007011C patent/CY2007011I2/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2314593T3 (es) | Forma cristalina alfa de ranelato de estroncio, su procedimiento de preparacion y composiciones farmaceuticas que la contienen. | |
RU2001118035A (ru) | Этанолят азитромицина, процесс получения и содержащие его фармацевтические составы | |
PE20090124A1 (es) | Composicion farmaceutica que comprende cristales de aripiprazol b de baja higroscopicidad y procedimiento de preparacion de la misma | |
KR970042550A (ko) | Cdch의 신규 결정성 변형체, 그의 제조 방법 및 이 변형체를 함유하는 제약 제제 | |
KR940005636A (ko) | 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 수화물 결정 및 이들의 제조방법 | |
JPS6236381A (ja) | グアニン誘導体結晶性一水和物、その製造方法及びそれを含む抗ウイルス剤 | |
KR900001422B1 (ko) | 5-클로로-3-(2-테노일)-2-옥신돌-1-카복스아미드의 무수 결정성 나트륨 염 | |
PE20010209A1 (es) | Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticas | |
SK24389A3 (en) | Crystalline additive salts of 7-alpha[(2-aminothiazol-4-yl)- -alpha-(z)-methoxyiminoacetamido]-3-[(1-methyl-1- -pyrrolidino)methyl]-3-cephem-4-carboxylate, method for producing and pharmaceutical compositions comprising same | |
KR20070045101A (ko) | 에스오메프라졸 스트론튬염 또는 이의 수화물, 이의제조방법 및 이를 포함하는 약학 조성물 | |
PT86121B (pt) | Processo para a preparacao de sal de acido 2-{(2,6-diclorofenil)-amino}-benzeno-acetico com uma base organica ciclica e de composicoes farmaceuticas contendo o mesmo | |
HU912768D0 (en) | Process for producing codeinic salt of a substituted carboxylic acid as well as pharmaceutical preparative containing said compound | |
ES2226357T3 (es) | Nitratos que forman parte de un medicamento antiulceroso. | |
RU2003134076A (ru) | Клатрат гидрата азитромицина с 1,2,-пропиленгликолем, способ его получения и содержащая его фармацевтическая композиция | |
CY1107112T1 (el) | Κρυσταλλοι τοζιλικου suplatast | |
ES2209110T3 (es) | Nuevos derivados de acidos aninoalcano sulfonicos, fosfonicos y fosfinicos, su preparacion y su uso como medicamentos. | |
RU2004127981A (ru) | Способ получения натриевой соли правастатина в кристаллической форме и натриевая соль правастатина, полученная этим способом | |
RU2008103699A (ru) | Кристаллические формы динатриевой соли n-(-5-хлорсалицило-)-8-аминокаприловой кислоты | |
DK0480455T3 (da) | Optisk aktive thienotriazolodiazepinforbindelser | |
FI66008C (fi) | Foerfarande foer framstaellning av kristallint anhydrat av natrium-7-(d-2-hydroxi-2-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat | |
ATE127465T1 (de) | Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen. | |
PT1218401E (pt) | 4-benzilaminoquinolinas conjugadas com acido biliar e seus heterociclicos metodos de sua producao medicamentos contendo estes compostos e sua aplicacao | |
JPS5726692A (en) | Preparation of stable crystal of salt of ceftizoxime | |
JP3574185B2 (ja) | 無水クエン酸トリマグネシウムおよびその製法 | |
US2556688A (en) | Pharmaceutical methionine composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |